- Home
- PMI vs SMTI Comparison
PMI vs SMTI Comparison
Compare PMI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMI | SMTI |
|---|---|---|
| Founded | 1981 | 1982 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.7M | 169.0M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | PMI | SMTI |
|---|---|---|
| Price | $1.47 | $19.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | ★ 1.6M | 68.6K |
| Earning Date | 01-01-0001 | 04-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $20.66 |
| Revenue Next Year | N/A | $17.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $1.30 | $18.29 |
| 52 Week High | $13.68 | $36.31 |
Technical Indicators
Market Signals| Indicator | PMI | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 39.54 | 38.14 |
| Support Level | $1.30 | $18.29 |
| Resistance Level | $2.50 | $20.00 |
| Average True Range (ATR) | 0.26 | 1.09 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 19.17 | 30.70 |
Price Performance
Historical ComparisonAbout PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.